Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Data Page
  • Published:

Drought-tolerant varieties begin global march

Nature Biotechnology volume 32, page 308 (2014)Cite this article

Subjects

Access through your institution
Buy or subscribe

175.2 million hectares of biotech crops were grown globally in 2013. In the United States, the first commercialized drought-tolerant maize (MON87460) expressing Bacillus subtilis cold shock protein B (cspB) was planted by 2,000 farmers over 50,000 hectares. Indonesia also approved drought-tolerant sugarcane expressing choline dehydrogenase (betA), which accumulates membrane-protectant glycine betaine. Other drought-resistant varieties of sugarcane, maize, wheat and rice are also in field trials in Argentina, Brazil, India, Egypt, South Africa, Kenya and Uganda. Brazil continues to lead the world in annual growth (10%) of transgenic acreage.

Global area by transgenic trait

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Andrew Marshall is Chief Editor at Nature Biotechnology,

    Andrew Marshall

Authors
  1. Andrew Marshall
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marshall, A. Drought-tolerant varieties begin global march. Nat Biotechnol 32, 308 (2014). https://doi.org/10.1038/nbt.2875

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt.2875

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research